Task: Answer the multiple-choice question.
Question: Which compound exhibits a -1.132% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. CCOC(=O)N1CCN(C(c2ccc(C)cc2)c2sc3nc(C)nn3c2O)CC1
b. CCN1CCN(c2nc3c(c(=O)[nH]2)CCCC3)CC1
c. O=C(CSc1nc2ncccc2[nH]1)NC1CCCC1
Answer: b. CCN1CCN(c2nc3c(c(=O)[nH]2)CCCC3)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN1CCN(c2nc3c(c(=O)[nH]2)CCCC3)CC1
CCN1CCN(c2nc3c(c(=O)[nH]2)CCCC3)CC1
2-(4-ethylpiperazin-1-yl)-5,6,7,8-tetrahydro-3H-quinazolin-4-one